No Image

Viloxazine (Qelbree) for ADHD

May 19, 2021 Auto Bot 0

Date:  June 28, 2021 Issue #:  1627 Summary:  The FDA has approved viloxazine extended-release capsules (Qelbree – Supernus) for treatment of attention-deficit/hyperactivity disorder (ADHD) in […]

Adult Exposure to Lead

September 3, 2020 Auto Bot 0

“Children in approximately 4 million households in the United States are being exposed to high levels of lead.” As I discuss in my video The […]